NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00609284,Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux,https://clinicaltrials.gov/study/NCT00609284,2007-01,COMPLETED,The aim of the trial is to study the efficacy of adding concomitant chemotherapy (carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck cancer.,NO,HNSCC,"DRUG: cetuximab|DRUG: Carboplatin, 5FU concomitant|RADIATION: Radiotherapy","Progression free survival, 3 years","Loco-regional control, 3 years",,Groupe Oncologie Radiotherapie Tete et Cou,,ALL,"ADULT, OLDER_ADULT",PHASE3,406,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,GORTEC 2007-01,2008-02-15,2018-03-26,2019-03-26,2008-02-07,,2020-04-15,"Centre hospitalier Annecy, Annecy, 74000, France|Centre Jean Perrin, Clermont Ferrand, 63000, France|Centre Guillaume Le Conquerant, Le Havre, 76600, France|Centre hospitalier de Bretagne Sud, Lorient, 56322, France|Institut Gustave Roussy, Villejuif, 94805, France",
